Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026)
Ardelyx (ARDX) posted Other Working Capital Changes of -$571000.0 for Q1 2026, up 76.59% on a QoQ basis from -$2.4 million in Q4 2025, and up 42.38% year-over-year from -$401035.4 in Q1 2025.
Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Ardelyx's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$571000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 42.38% year-over-year to -$571000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (up 19.03% YoY) and the FY2025 annual result came in at -$3.9 million, up 14.71% from the prior year.
- Other Working Capital Changes was -$571000.0 for Q1 2026 at Ardelyx, up from -$2.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.4 million in Q1 2024 and bottomed at -$1.8 million in Q2 2023.
- A 5-year average of $1.3 million and a median of $673000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 497.07% — and 2024, when it slumped 321.27%.
- Ardelyx's Other Working Capital Changes stood at $3.3 million in 2022, then tumbled by 175.09% to -$2.4 million in 2023, then surged by 50.92% to -$1.2 million in 2024, then sank by 103.25% to -$2.4 million in 2025, then soared by 76.59% to -$571000.0 in 2026.
- Business Quant data shows ARDX's Other Working Capital Changes at -$571000.0 in Q1 2026, -$2.4 million in Q4 2025, and -$206000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 327,000.00 |
| Dec 31, 2024 | 327,000.00 |
| Dec 31, 2024 | 327,000.00 |
| Sep 30, 2024 | -400,000.00 |
| Sep 30, 2024 | -400,000.00 |